Status:

COMPLETED

Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants

Lead Sponsor:

Janssen Research & Development, LLC

Conditions:

Obesity

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to compare the effects of canagliflozin and phentermine to those of placebo to promote on a change in body weight over a 26 week period.

Detailed Description

This is a randomized (the study medication is assigned by chance), double-blind (neither physician nor participant knows the identity of the assigned treatment), placebo-controlled (an inactive substa...

Eligibility Criteria

Inclusion

  • Must have BMI \>=30 kg/m2 and \<50 kg/m2 at screening or BMI \>=27 kg/m2 and \<50 kg/m2 at screening in the presence of a comorbidity of hypertension and/or dyslipidemia
  • Must have stable weight, ie, change of \< =5% in the 3 months before screening
  • Must agree to utilize a highly effective method of birth control

Exclusion

  • An established diagnosis of diabetes mellitus
  • Has a history of obesity with a known secondary cause (eg, Cushing's disease/syndrome)
  • Has a history of hereditary glucose-galactose malabsorption or primary renal glycosuria
  • Myocardial infarction, unstable angina, revascularization procedure, or cerebrovascular accident within 12 weeks before screening
  • Has an Glycated hemoglobin (HBA1c) greater than or equal (\>=) to 65 percent
  • An average of 3 seated blood pressure (BP) readings of systolic BP \>= 160 mm Hg and/or Diastolic BP \>= 100 millimeters of mercury at screening

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

335 Patients enrolled

Trial Details

Trial ID

NCT02243202

Start Date

September 1 2014

End Date

June 1 2015

Last Update

October 6 2016

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Phoenix, Arizona, United States

2

Walnut Creek, California, United States

3

Jacksonville, Florida, United States

4

Meridian, Idaho, United States